Peregrine Pharmaceuticals Investigational Site — St. Petersburg, Florida

Peregrine Pharmaceuticals Investigational Site is a clinical research site located in St. Petersburg, Florida, United States 33705.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Peregrine Pharmaceuticals Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Non-Small-Cell Lung Cancer Stage IIIB, Non-Small-Cell Lung Cancer Stage IV, Non-Small-Cell Lung Cancer Metastatic.

Sponsors: Peregrine Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in St. Petersburg

Browse all research sites in Florida · View every site in St. Petersburg

• Johns Hopkins All Children's Hospital, 501 6th Avenue South (Site 840048)
• University of South Florida Allergy Immunology Clinic
• All Children's Hospital, St. Petersburg
• BayCare Medical Group Neurology at St. Anthony's Hospital
• University of South Florida at Tampa (5018)
• John's Hopkins Al Children's Hospital
• University of South Florida - Rothman Center
• Palms of Pasadina Hospital
• CFF Care Center & Pediatric Program All Children's Hospital
• University of Florida Rothman Center
• Florida All Children's Hospital
• Palms of Pasadena Hospital, Saint Petersburg, Florida

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Peregrine Pharmaceuticals Investigational Site?

Peregrine Pharmaceuticals Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Peregrine Pharmaceuticals Investigational Site conducted?

Peregrine Pharmaceuticals Investigational Site has 1 clinical trials on record. Their work covers Non-Small-Cell Lung Cancer Stage IIIB, Non-Small-Cell Lung Cancer Stage IV, Non-Small-Cell Lung Cancer Metastatic.

Is Peregrine Pharmaceuticals Investigational Site accredited by Crixeo Clinical Trials?

Peregrine Pharmaceuticals Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Peregrine Pharmaceuticals Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.